Quantifying the overlap in top marker genes of tumor states across patients of the same subtype, we observed greater divergence in markers representing MBC tumor states, implicating higher intertumoral heterogeneity in MBC samples than that in TNBC and ER+ samples (Fig. 2o), consistent with the known morphological heterogeneity of MBCs49. This evidence concerns the gene ESR1 and neoplasm.